Consistency in treatment and adhering to the recommended dosage is key to realizing optimal outcomes
Figure 19: Photograph of frozen intestinal starting material being handled by Jan Wiberg (left) and Johnny Sderlund (right) in Mutt's laboratory, photographer unknown
The late-stage obesity drugs now in development, part of a rapidly expanding GLP-1 drug pipeline, layer in additional targets, amylin, GIP and glucagon among them, in an effort to deliver greater weight loss, better tolerability or more convenient dosing
With so much hype about weight-loss drugs (some hyped as miracle solutions), its tough to know what actually works
Safety monitoring should include periodic IGF-1 levels and fasting glucose checks, as growth hormone stimulation can affect glucose metabolism
Mechanistically, the KDM8-mediated PKM2 nuclear translocation results in the transcriptional activation of glycolytic program, including GLUT1, HK2, PKM2, LDHA, etc.) and downregulation of genes for pyruvate dehydrogenase complex (PDHA1 and PDHB1) to reduce the direction of pyruvate to mitochondria